Stock Events

Stock Events

Search...

Bellevue Life Sciences Acquisition Unit

$10.95

8

+$0+0% Tuesday 20:00

Statistics

Day High

0

Day Low

0

52W High

12

52W Low

0

Volume

0

Avg. Volume

320

Mkt Cap

-

P/E Ratio

-

Dividend Yield

-

Dividend

-

Earnings

20JanExpected

Q4 0

Q1 2022

Q3 2022

Q4 2022

0

0.33

0.67

1

Expected EPS

0

Actual EPS

0

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BLACU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

International Business Machines

IBM offers similar IT services and solutions, competing directly in the technology and consulting sectors.

HP Inc. provides a range of computing and other technological products, overlapping with ACS Global's product offerings.

Cisco Systems is a leader in networking and communications products and services, competing in the same technology infrastructure market.

Microsoft's extensive range of software products and cloud services competes with ACS Global's software solutions.

Google, through its cloud computing solutions and technological innovations, competes in the same digital services and products sector.

Apple's broad range of technology products, including hardware and software solutions, places it in direct competition with ACS Global.

Oracle provides database software and technology, cloud engineered systems, and enterprise software products that compete with ACS Global.

SAP's enterprise software and software-related services compete with ACS Global's offerings in the business solutions sector.

Adobe's software products directly compete with ACS Global's offerings in the digital media and marketing sectors.

Intel, as a major provider of semiconductor chips, competes with ACS Global in the technology hardware market.

About

Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.

Show more...

CEO

Country

US

Listings